Stasinos Chr. Sikalias · The science of compounding

Imidazolidinyl urea 50% w/v preservative solution

CGR-BR-003 · ANVISA — Formulário Nacional da Farmacopeia Brasileira, 2ª edição, Revisão 02 (2012)

Historical source editionCGR-BR-003Brazil

HISTORICAL SOURCE EDITION — compare with the current edition before use.

Dosage formLiquid base or auxiliary solution
Reference batch100 mL
Monograph version4.0
Source packagev4

Source formula

IngredientSource quantity
Imidazolidinyl urea50 g
Purified waterq.s. ad 100 mL

Quantities refer to the source batch. This website does not automatically scale formulas, assign doses or calculate BUD.

Description

Partial evidence

Liquid base or auxiliary solution: Imidazolidinyl urea 50% w/v preservative solution. Additional appearance criteria are not established by the specific text reviewed.

References: [1]

Use and action

Documented in source

Preservative concentrate.

References: [1]

Specifications

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Light

Partial evidence

For the finished product the source specifies:
Amber glass, protected from light, room temperature.

References: [1]

Air

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Water and solubility

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Humidity

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Temperature

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

pH and related incompatibilities

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Other incompatibilities

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Ingredient-specific information

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Personal protective equipment

Partial evidence

Complete formula-specific PPE is not specified. Select gloves, eye protection and exposure controls using the exact materials’ SDS and the local risk assessment.
Supplementary AEMPS framework: clean long-sleeved laboratory clothing, hair covering and dedicated footwear/overshoes. Powder handling requires suitable eye/respiratory protection; change gloves with activity or damage. Select the exact type/material using SDS and risk assessment.

References: [1] · [2]

Risks and precautions

Partial evidence

A complete formula-specific hazard classification is not established. Assess potency, dust/aerosol, allergens, solvents, microbial risk and cross-contamination using the actual materials and process. Absence of a flag does not establish absence of hazard.

References: [1]

Compounding conditions

Partial evidence

Follow the addition sequence, temperatures and times stated under Preparation Procedure. The specific monograph is not a complete qualification of the local facility/equipment.

References: [1]

BUD rationale

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.
The source period applies to its exact composition, method and packaging. It is not this batch’s expiry date and cannot be transferred to another vehicle/strength. Calculate the actual date in the blank batch record.

References: [1]

Bases and dependencies

Partial evidence

No separate base is identified in the dependency register. Check any commercial vehicles/compound excipients listed in the formula.

References: [1]

Equipment

Editorial checklist

Indicative checklist derived from the method: Balance of suitable resolution, Containers and mixing tools compatible with the materials. Selection/qualification is defined locally.

References: [1]

Preparation procedure

Documented in source

Dissolve in water with stirring and make to 100 mL.

References: [1]

Observations

Documented in source

50 g to 100 mL means 50% w/v. A dose in grams of this stock does not imply a 50% w/w stock.

References: [1]

Packaging

Documented in source

Amber glass, protected from light, room temperature.

References: [1]

Quality control

Not established

No specific information is established by the consulted sources. Complete this before local approval where critical to this preparation.

References: [1]

Storage

Documented in source

Amber glass, protected from light, room temperature.

References: [1]

Dispensing and directions

Partial evidence

No additional special directions are established beyond the source route, storage and notes. Complete patient details, dose and directions from the prescription.

References: [1]

Labelling

editorial_specimen

Imidazolidinyl urea 50% w/v preservative solution
Strength/variant: __________ Quantity: __________
Batch: __________ Prepared: __________ Use by: __________
Για εργαστηριακή ενσωμάτωση / For incorporation during compounding
Dose/directions: __________
Storage: Amber glass, protected from light, room temperature.

References: [1]

Sources and traceability

  1. ANVISA — Formulário Nacional da Farmacopeia Brasileira, 2ª edição, Revisão 02 (2012)

    2012, 2nd ed., Rev. 02 — superseded · PDF pp. 201 · A2

    Review date reported in supplied metadata: 2026-09-10

  2. PN/L/PG/002/00 INDUMENTARIA

    Διαθέσιμο κείμενο / Retrieved text · PDF pp. 1–5 · A1

    Review date reported in supplied metadata: 2026-09-10

Provenance and reuse

This record comes from the supplied v4 collection. Primary-source rights and licences remain separate. No new comprehensive licence review has been performed for the earlier 239 records.

SHA-256 of the supplied PDF: 0c175c5ffa4fa8707cc1a3b72ef75d618184426da07878d119a0f5dded5105eb